Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2019005643) METHOD FOR TREATING FIBRILLAR COLLAGENOUS CONDITIONS
Latest bibliographic data on file with the International Bureau    Submit observation
Pub. No.: WO/2019/005643 International Application No.: PCT/US2018/039177
Publication Date: 03.01.2019 International Filing Date: 23.06.2018
IPC:
A61K 45/06 (2006.01) ,G01N 33/49 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
45
Medicinal preparations containing active ingredients not provided for in groups A61K31/-A61K41/132
06
Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
G PHYSICS
01
MEASURING; TESTING
N
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33
Investigating or analysing materials by specific methods not covered by groups G01N1/-G01N31/131
48
Biological material, e.g. blood, urine; Haemocytometers
483
Physical analysis of biological material
487
of liquid biological material
49
blood
Applicants:
NEXT SCIENCE IP HOLDINGS PTY LTD [AU/AU]; Suite 19.02, Level 19 Tower A, The Zenith Building 821 Pacific Highway Chatswood, New South Wales 2067, AU
Inventors:
MYNTTI, Matthew F.; US
Agent:
BURLESON, David G.; US
ZOLLINGER, III, Frederick H.; US
Priority Data:
62/525,09726.06.2017US
Title (EN) METHOD FOR TREATING FIBRILLAR COLLAGENOUS CONDITIONS
(FR) MÉTHODE DE TRAITEMENT DE PATHOLOGIES DES FIBRES DE COLLAGÈNE
Abstract:
(EN) A topical composition can be used to treat or inhibit onset of fibrillar collagenous growths, including but not limited to keloids. The composition includes elemental iodine carried in a non-migratory vehicle. Application of the composition can result in a significant reduction in the size of such a growth or, if applied to an area of skin susceptible to such a growth, inhibit the onset thereof.
(FR) L'invention concerne une composition topique qui peut être utilisée pour traiter des excroissances de fibres de collagènes ou inhiber leur apparition, y compris, mais sans y être limitées, des chéloïdes. La composition comprend de l'iode élémentaire, porté par un véhicule non migrant. L'application de la composition peut conduire à une réduction considérable de la taille d'une telle excroissance ou, si elle est appliquée sur une zone de peau susceptible de connaître une telle excroissance, à inhiber son apparition.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)